Patent details
EP3145508 Title: CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
Basic Information
- Publication number:
- EP3145508
- PCT Application Number:
- US2015031470
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP157957077
- PCT Publication Number:
- WO2015179334
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
- French Title of Invention:
- NANOPARTICULES DE CLÉVIDIPINE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
- German Title of Invention:
- CLEVIDIPINNANOPARTIKEL UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/07/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 03/08/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/07/2023
- Unitary Effect Registration Date:
- 03/08/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/05/2015
- Grant date:
- 05/07/2023
- EP Publication Date:
- 29/03/2017
- PCT Publication Date:
- 26/11/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/07/2023
- EP B1 Publication Date:
- 05/07/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/05/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/06/2023
- Name:
- Chiesi Farmaceutici S.p.A.
- Address:
- Via Palermo, 26/A, 43122 Parma, Italy (IT)
Inventor
1
- Name:
- KANTER, Monika
- Address:
- Germany (DE)
2
- Name:
- TÜRELI, Akif Emre
- Address:
- Germany (DE)
3
- Name:
- MOTHERAM, Rajeshwar
- Address:
- United States (US)
4
- Name:
- HANLEY, Sr. David C.
- Address:
- United States (US)
Priority
- Priority Number:
- 201462000119 P
- Priority Date:
- 19/05/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/10; A61K 9/19; A61K 9/51; A61K 47/10; A61K 31/4422;
Publication
European Patent Bulletin
1
- Issue number:
- 202327
- Publication date:
- 05/07/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202336
- Publication date:
- 06/09/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202336
- Publication date:
- 06/09/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|